Stock Events

Stock Events

Search...

CRISPR Therapeutics (CRSP) Q1 2026 Earnings

12FebConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-2.4

-1.99

-1.58

-1.16

Details

Expected EPS

-1.162892

Actual EPS

-1.37

Surprise EPS

-0.21

Surprise Percent

+17.81%

Description

CRISPR Therapeutics (CRSP) has reported earnings of -1.37 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.